catalent glp 1 Novo Nordisk parent to acquire to shore up weight-loss drug production Catalent x Novo: GLP-1 and

Learn what causes "Ozempic teeth," how GLP-1 side effects affect your oral health, and what you can do.

I assume that the study is finished now

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinsons disease, finds a new study led by UCL researchers.

The World Obesity Atlas 2024 reports over 1.5 billion projected cases by 2035, highlighting its growing threat among pediatric and adult populations globally

GLP-1 medications like Wegovy and Zepbound can produce 1522% body weight loss

While GLP-1 weight loss peptides such as semaglutide and tirzepatide have become buzzworthy for th...